Albemarle Refocuses On Lithium With Ketjen Sale And Kemerton Idling
Albemarle (NYSE:ALB) is selling a controlling stake in its Ketjen refining catalyst business as part of a broader restructuring and cost-cutting plan. The company is also idling one train at its Kemerton lithium hydroxide plant. It expects this move to be accretive to earnings without affecting lithium volumes. Together, these steps signal a tighter focus on core lithium operations and are intended to improve financial flexibility and profitability. Albemarle, a major producer in the...
Albemarle (NYSE:ALB) is selling a controlling stake in its Ketjen refining catalyst business as part of a broader restructuring and cost-cutting plan. The company is also idling one train at its Kemerton lithium hydroxide plant. It expects this move to be accretive to earnings without affecting lithium volumes. Together, these steps signal a tighter focus on core lithium operations and are intended to improve financial flexibility and profitability. Albemarle, a major producer in the...